Advertisement
Advertisement

VKTX

VKTX logo

Viking Therapeutics, Inc

34.22
USD
Sponsored
-1.76
-4.89%
Aug 20, 13:40 UTC -4
Open

Viking Therapeutics, Inc Profile

About

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.

Info & Links

CEO

Brian Lian

Headquarters

9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.vikingtherapeutics.com

Auditor

CBIZ CPAs P.C.

Share holders

8

Employees

53

Viking Therapeutics, Inc Statistics

Valuation Measures

Market Capitalization2

3.99B

Enterprise Value

3.87B

Enterprise Value/EBITDA(ttm)

-6.84

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

9.53

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-94.56%

Return on Invested Capital(ttm)

-100.30%

Return on Assets(ttm)

-82.75%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-565.50M

Net Income Available to Common(ttm)

-534.80M

Diluted EPS(ttm)

-4.66

Share Statistics

Beta (5Y Monthly)

0.69

52-Week Change

40.48%

S&P 500 52-Week Change

18.90%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

116.65M

Dividend Yield

0.00%

Float4

110.47M

% Held by Insiders

5.30%

% Held by Institutions

76.03%

Balance Sheet

Total Cash(mrq)

501.66M

Total Cash Per Share(mrq)

4.30

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.72%

Quick Ratio(mrq)

4.72%

Book Value Per Share(mrq)

3.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.06

Free Cash Flow(ytd)

-239.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement